Toor Amir A, Sabo Roy T, Roberts Catherine H, Moore Bonny L, Salman Salman R, Scalora Allison F, Aziz May T, Shubar Ali Ali S, Hall Charles E, Meier Jeremy, Thorn Radhika M, Wang Elaine, Song Shiyu, Miller Kristin, Rizzo Kathryn, Clark William B, McCarty John M, Chung Harold M, Manjili Masoud H, Neale Michael C
Bone Marrow Transplant Program, Massey Cancer Center, Department of Internal Medicine, Virginia Commonwealth University, Richmond, Virginia.
Department of Biostatistics, Virginia Commonwealth University, Richmond, Virginia.
Biol Blood Marrow Transplant. 2015 Jul;21(7):1237-45. doi: 10.1016/j.bbmt.2015.03.011. Epub 2015 Apr 4.
Systems that evolve over time and follow mathematical laws as they evolve are called dynamical systems. Lymphocyte recovery and clinical outcomes in 41 allograft recipients conditioned using antithymocyte globulin (ATG) and 4.5-Gy total body irradiation were studied to determine if immune reconstitution could be described as a dynamical system. Survival, relapse, and graft-versus-host disease (GVHD) were not significantly different in 2 cohorts of patients receiving different doses of ATG. However, donor-derived CD3(+) cell reconstitution was superior in the lower ATG dose cohort, and there were fewer instances of donor lymphocyte infusion (DLI). Lymphoid recovery was plotted in each individual over time and demonstrated 1 of 3 sigmoid growth patterns: Pattern A (n = 15) had rapid growth with high lymphocyte counts, pattern B (n = 14) had slower growth with intermediate recovery, and pattern C (n = 10) had poor lymphocyte reconstitution. There was a significant association between lymphocyte recovery patterns and both the rate of change of donor-derived CD3(+) at day 30 after stem cell transplantation (SCT) and clinical outcomes. GVHD was observed more frequently with pattern A, relapse and DLI more so with pattern C, with a consequent survival advantage in patients with patterns A and B. We conclude that evaluating immune reconstitution after SCT as a dynamical system may differentiate patients at risk of adverse outcomes and allow early intervention to modulate that risk.
随时间演变并在演变过程中遵循数学规律的系统被称为动态系统。研究了41例接受抗胸腺细胞球蛋白(ATG)和4.5戈瑞全身照射预处理的同种异体移植受者的淋巴细胞恢复情况及临床结局,以确定免疫重建是否可被描述为一个动态系统。接受不同剂量ATG的两组患者在生存率、复发率和移植物抗宿主病(GVHD)方面无显著差异。然而,较低ATG剂量组的供体来源CD3(+)细胞重建更优,且供体淋巴细胞输注(DLI)的情况较少。绘制了每个个体随时间的淋巴细胞恢复情况,显示出三种S形生长模式之一:模式A(n = 15)生长迅速,淋巴细胞计数高;模式B(n = 14)生长较慢,恢复程度中等;模式C(n = 10)淋巴细胞重建较差。淋巴细胞恢复模式与干细胞移植(SCT)后第30天供体来源CD3(+)的变化率及临床结局之间存在显著关联。模式A更常观察到GVHD,模式C更常出现复发和DLI,因此模式A和B的患者具有生存优势。我们得出结论,将SCT后的免疫重建评估为一个动态系统可能会区分有不良结局风险的患者,并允许进行早期干预以调节该风险。